ACLX
Price
$63.94
Change
-$0.09 (-0.14%)
Updated
Jun 26, 03:22 PM (EDT)
Capitalization
3.53B
53 days until earnings call
CYTK
Price
$33.44
Change
+$0.33 (+1.00%)
Updated
Jun 26, 01:15 PM (EDT)
Capitalization
3.95B
35 days until earnings call
Interact to see
Advertisement

ACLX vs CYTK

Header iconACLX vs CYTK Comparison
Open Charts ACLX vs CYTKBanner chart's image
Arcellx
Price$63.94
Change-$0.09 (-0.14%)
Volume$300
Capitalization3.53B
Cytokinetics
Price$33.44
Change+$0.33 (+1.00%)
Volume$400
Capitalization3.95B
ACLX vs CYTK Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. CYTK commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a StrongBuy and CYTK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ACLX: $64.03 vs. CYTK: $33.11)
Brand notoriety: ACLX and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 76% vs. CYTK: 65%
Market capitalization -- ACLX: $3.53B vs. CYTK: $3.95B
ACLX [@Biotechnology] is valued at $3.53B. CYTK’s [@Biotechnology] market capitalization is $3.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while CYTK’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 3 bearish.
  • CYTK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ACLX and CYTK are a good buy in the short-term.

Price Growth

ACLX (@Biotechnology) experienced а +0.33% price change this week, while CYTK (@Biotechnology) price change was +1.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.62%. For the same industry, the average monthly price growth was +32.12%, and the average quarterly price growth was +14.94%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

CYTK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.95B) has a higher market cap than ACLX($3.53B). ACLX YTD gains are higher at: -16.508 vs. CYTK (-29.613). ACLX has higher annual earnings (EBITDA): -153.96M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. ACLX (543M). ACLX has less debt than CYTK: ACLX (53.2M) vs CYTK (791M). ACLX has higher revenues than CYTK: ACLX (76.8M) vs CYTK (19.2M).
ACLXCYTKACLX / CYTK
Capitalization3.53B3.95B89%
EBITDA-153.96M-513.62M30%
Gain YTD-16.508-29.61356%
P/E RatioN/AN/A-
Revenue76.8M19.2M400%
Total Cash543M938M58%
Total Debt53.2M791M7%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXCYTK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 21 days ago
87%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 10 days ago
78%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BITW66.002.00
+3.12%
Bitwise 10 Crypto Index Fund
GLO5.320.01
+0.28%
Clough Global Opportunities Fund
AVLC69.66-0.08
-0.11%
Avantis U.S. Large Cap Equity ETF
ECOW21.56-0.04
-0.16%
Pacer Emerging Markets Cash Cows 100 ETF
FAS159.70-1.76
-1.09%
Direxion Daily Financial Bull 3X ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IDYA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-0.87%
IDYA - CYTK
48%
Loosely correlated
+1.06%
IMVT - CYTK
47%
Loosely correlated
-1.56%
KRYS - CYTK
46%
Loosely correlated
-0.81%
ROIV - CYTK
44%
Loosely correlated
-1.21%
ACLX - CYTK
44%
Loosely correlated
+1.07%
More